Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality
Mycoses · 2025
DOI: 10.1111/myc.70032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Tarsila Vieceli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Endocarditis, Candida, Candidiasis, Candidemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
Although there are some studies evaluating CIE incidence and associated risk factors, none assessed mortality several months after the Candida spp. BSI episode. We aimed to assess risk factors for CIE and outcomes, including 1‐year mortality, in patients with Candida spp. BSI in a public tertiary‐care teaching hospital in Brazil. Patients and Methods Retrospective case–control, followed by a cohort study, with adult patients who presented a Candida spp. BSI. Participants were eligible if they had at least one echocardiogram performed no longer than 3 days before Candida spp. BSI diagnosis and thereafter during the respective hospital admission. CIE diagnosis was defined by the presence of two major Duke criteria.
Results
We studied 164 patients (median age: 57.6 years) with a median Charlson comorbidity index of 3 points. Most patients were female (54.9%), were on haemodialysis (54.9%), and 4.6% had a preexisting moderate/severe heart valve disease. C. albicans (36.2%) and C. parapsilosis complex (34.4%) were the most frequent Candida species identified. CIE was detected in 10 patients (6.1%; 95% CI: 2.4%–9.8%). In the multivariable analysis, age and C. parapsilosis complex remained as independent predictors of CIE. There was no significant difference between CIE and no CIE groups in 1‐year mortality after Candida spp. BSI diagnosis and hospital discharge.
Discussion
Considering the low costs and hazards associated with an echocardiogram, performing it systematically in all patients with Candida spp. BSI might improve CIE diagnosis and ultimately survival rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
- Internal Medicine Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
- School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
- Microbiology Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
- Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
ORCID-Profile: Tarsila Vieceli, Fernando Pivatto Júnior
Zitieren
APA
Vieceli, T., Giordani, B. M., de Magalhães, G. A., Serena, G. C., Aquino, V. R., Borges, V. S., Zavascki, A. P., & Pivatto Júnior, F. (2025). Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality. Mycoses. https://doi.org/10.1111/myc.70032
Vancouver
Vieceli T, Giordani BM, de Magalhães GA, Serena GC, Aquino VR, Borges VS, et al. Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality. Mycoses. 2025. doi:10.1111/myc.70032
BibTeX
@article{Vieceli2025,
author = {Vieceli, Tarsila and Giordani, Betina Maria and de Magalhães, Gabriel Azeredo and Serena, Guilherme Carvalho and Aquino, Valério Rodrigues and Borges, Vicente Stolnik and Zavascki, Alexandre Prehn and Pivatto Júnior, Fernando},
title = {Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70032}
}
EUVIMED